Shortages and supply adjustments for generic drugs
First written in FY2022-Q2. 3 of 4 entries say "Restated". Latest entry: FY2023.
2 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「In addition to ensuring a stable supply of pharmaceuticals, we have worked to deliver COVID-19 vaccines and treatments and address generic pharmaceuticals that continue to face shortages and supply-demand adjustments.」
Generic drugs subject to continuing shortages and supply-demand adjustments are identified as an ongoing issue requiring action to ensure stable supply. - FY2023-Q2RestatedAnnual report
「In addition to ensuring a stable supply of pharmaceuticals, we are making efforts to deliver COVID-19 vaccines and treatments and to address generic pharmaceuticals that continue to face shortages and supply-demand adjustments.」
Generic drugs subject to continuing shortages and supply-demand adjustments are identified as an ongoing issue requiring action to ensure stable supply. - FY2022-Q3RestatedAnnual report
「We are also making efforts to address generic pharmaceuticals that continue to face shortages and supply adjustments.」
Generic drugs subject to continuing shortages and supply adjustments are identified as an ongoing issue requiring action to ensure stable supply. - FY2022-Q2First statedAnnual report
「We are also making efforts to address generic pharmaceuticals that continue to face shortages and supply adjustments.」
Generic drugs subject to continuing shortages and supply adjustments have been identified for the first time as an ongoing issue requiring action to ensure stable supply.